This clinical trial studies statewide optimization of lung cancer screening (LCS) in Kentucky using the Quality Implementation of Lung Screening (QUILS™) System. Data from the Kentucky Cancer Registry shows that LCS implementation has contributed to a rapid decline in late-stage lung cancer diagnosis at twice the national average. Further, the declines are more than three times the national average decline in Kentucky's Central Appalachian region. Kentucky-based multilevel initiatives are needed to expand and accelerate this leading role and extend the LCS opportunity to more Kentuckians who are at increased risk of lung cancer. This trial may be able to accelerate optimal high-quality implementation of LCS utilizing the QUILS™ System and reduce the burden of lung cancer by assisting lung cancer screening programs located throughout Kentucky in implementing best practices in lung cancer screening by integrating the QUILS™ System domains and elements into their screening programs.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Enrollment
35,500
The QUILS System is a health services research intervention designed to improve the quality of lung cancer screening programs. The intervention includes QUILS Index Assessment, QUILS Audit and Feedback Report and Presentation, QUILS Resource Portal, site-specific action plans, and formative evaluation activities.
King's Daughter's Medical Center
Ashland, Kentucky, United States
RECRUITINGTaylor Regional Hospital
Campbellsville, Kentucky, United States
RECRUITINGSt. Elizabeth Healthcare
Edgewood, Kentucky, United States
RECRUITINGGeorgetown Cancer Treatment Cancer
Georgetown, Kentucky, United States
RECRUITINGTJ Samson Community Hospital
Glasgow, Kentucky, United States
RECRUITINGHazard Appalachian Regional Healthcare Medical Center
Hazard, Kentucky, United States
RECRUITINGLexington VA Health Care System
Lexington, Kentucky, United States
RECRUITINGSt. Joseph Health (Catholic Health Initiatives)
Lexington, Kentucky, United States
RECRUITINGUniversity of Kentucky Markey Cancer Center
Lexington, Kentucky, United States
RECRUITINGThe James Graham Brown Cancer Center at University of Louisville
Louisville, Kentucky, United States
RECRUITING...and 7 more locations
Change in Quality Improvement Lung Cancer Screening (QUILS) Index Assessment Score
The QUILS Index Assessment is a program-level measure of lung cancer screening implementation quality. Scores range from 0 to 95, with a higher score indicating higher quality implementation of lung cancer screening practices. The outcome measure is the change in total QUILS Index score from Baseline to 12 months.
Time frame: Baseline and Month 9
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.